Biological characterization of MVE-2 and poly ICLC.
D000818:Animals; D002266:Carboxymethylcellulose Sodium / Q000494:pharmacology* / Q000031:analogs & derivatives; D003520:Cyclophosphamide / Q000494:pharmacology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D006410:Hematopoiesis / Q000187:drug effects; D007694:Killer Cells, Natural / Q000187:drug effects; D008264:Macrophages / Q000187:drug effects; D008297:Male; D008747:Methylcellulose / Q000031:analogs & derivatives*; D051379:Mice; D008807:Mice, Inbred BALB C; D010455:Peptides / Q000494:pharmacology*; D011070:Poly I-C / Q000494:pharmacology*; D011107:Polylysine / Q000494:pharmacology* / Q000031:analogs & derivatives; D011108:Polymers / Q000494:pharmacology*; D011713:Pyran Copolymer / Q000494:pharmacology*; D013997:Time Factors
D010455:Peptides; D011108:Polymers; D011107:Polylysine; D011713:Pyran Copolymer; C019531:poly ICLC; D003520:Cyclophosphamide; D008747:Methylcellulose; D002266:Carboxymethylcellulose Sodium; D011070:Poly I-C